[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335043-105":59,"doc-detail-335043-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","screening-and-identification-of-mirnas-negatively-regulating-fam83awnt-catenin-signaling-pathway-in-non-small-cell-lung-cancer-research-report","Screening and identification of miRNAs negatively regulating FAM83A/Wnt/β-catenin signaling pathway in non-small cell lung cancer - Research report","","Non-small cell lung cancer (NSCLC) is dominated by Wnt/β-catenin pathway activation, with FAM83A markedly upregulated and stabilizing β-catenin to drive downstream transcription. The study screened for down-regulated miRNAs in lung cancer using FAM83A as the target, identifying miR-1 as a negative regulator. miR-1 directly targets FAM83A by dual luciferase assays and suppresses Wnt signaling by reducing AXIN2, CyclinD1, and C-MYC while decreasing β-catenin nuclear translocation. miR-1 also promotes β-catenin degradation, inhibits NSCLC proliferation, migration, and invasion, and is proposed as a therapeutic miRNA candidate for NSCLC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/screening-and-identification-of-mirnas-negatively-regulating-fam83awnt-catenin-signaling-pathway-in-non-small-cell-lung-cancer-research-report/335043/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/screening-and-identification-of-mirnas-negatively-regulating-fam83awnt-catenin-signaling-pathway-in-non-small-cell-lung-cancer-research-report/335043.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which miRNA was identified as a negative regulator of FAM83A in lung cancer?","Question",{"text":112,"@type":113},"miR-1 was identified as a negative regulator of FAM83A in lung cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the direct targeting relationship between miR-1 and FAM83A validated?",{"text":117,"@type":113},"The study confirmed FAM83A as a direct target gene of miR-1 using dual luciferase reporter assays.",{"name":119,"@type":110,"acceptedAnswer":120},"What cellular effects did miR-1 overexpression have on NSCLC cells?",{"text":121,"@type":113},"Overexpression of miR-1 attenuated FAM83A expression and suppressed Wnt signaling, reduced β-catenin nuclear translocation, promoted β-catenin degradation, and inhibited NSCLC cell proliferation, migration, and invasion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335043,1790115009,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nScreening and identification of miRNAs negatively regulating FAM83A/Wnt/β‑catenin signaling pathway in non‑small cell lung cancer  \nWenbin Yuan1, Wei Liu1, Huili Huang1, Xingyu Chen1, Rui Zhang1, Hao Lyu1, Shuai Xiao1, Dong Guo1, Qi Zhang1, Declan William Ali3, Marek Michalak4, Xing‑Zhen Chen2,  \nCefan Zhou1* & Jingfeng Tang1*  \nThe prevalence of non‑small cell lung cancer (NSCLC) accounts for 85% of all lung cancers, with the Wnt/β‑catenin signaling pathway exhibiting robust activation in this particular subtype. The expression of FAM83A (family with sequence similarity 83, member A) has been found to be significantly upregulated in lung cancer, leading to the stabilization of β‑catenin and activation of the Wnt signaling pathway. In this study, we conducted a screening of down‑regulated miRNAs in lung cancer with FAM83A as the target. Ultimately, we identified miR‑1 as a negative regulator of FAM83A and confirmed that FAM83A is a direct target gene of miR‑1 through dual luciferase reporter assays. The overexpression of miR‑1 significantly attenuated the expression level of FAM83A and suppressed the Wnt signaling pathway, leading to a reduction in the expression levels of downstream target genes AXIN2, CyclinD1, and C‑MYC. Additionally, it decreased the nuclear translocation of β‑catenin. In addition, overexpression of miR‑1 accelerated the degradation of β‑catenin by inhibiting FAM83A, promoted the assembly of β‑catenin degradation complex, and inhibited the proliferation, migration and invasion of NSCLC cells. In summary, miR‑1 may be a potential candidate miRNA for the treatment of NSCLC.  \nKeywords Non-small cell lung cancer, FAM83A, miR-1, Wnt/β-catenin  \nThe Wnt/β-catenin signaling pathway is known to undergo activating mutations in various cancers. However,β-catenin and APC mutations are uncommon in non-small cell lung cancer (NSCLC). Despite this, the Wnt/β -catenin signaling pathway still plays a crucial role in maintaining the proliferation of NSCLC cell lines, and inhibition of this pathway can significantly slow down the NSCLC process1. As a result of the suppression of the degradation complex in the activated Wnt signaling pathway, β-catenin that has been stabilized is transported into the nucleus and triggers the transcription of target genes downstream through its interaction with T cell factor (TCF)/lymphoid enhancer binding factor (LEF), which are transcription factors2. FAM83A, also known as BJ-TSA-9, exhibits significant upregulation in cases of lung carcinoma3. In our previous work, we found that FAM83A, through its the DUF1669 domain directly interacts with Arm repeats domain of β-catenin and promotes β-catenin nuclear transports to initiate transcription of target genes downstream of Wnt. Repression of FAM83A led to notable suppression of cellular growth, indicating that targeting FAM83A could be a promising strategy for cancer treatment4.  \n1Key Laboratory of Fermentation Engineering (Ministry of Education), National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education and Hubei Province), Hubei Key Laboratory of Industrial Microbiology, School of Life and Health Sciences, Hubei University of Technology, Wuhan 430068, People’s Republic of China. 2Membrane Protein Disease Research Group, Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. 3Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada. 4Department of  \nBiochemistry, University of Alberta, Edmonton, AB, Canada.*[email: cefan@hbut.edu.cn](email: cefan@hbut.edu.cn); [Jingfeng_hut@163.com](Jingfeng_hut@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nRNA-based therapies show promise in treating diseases that are currently considered incurable with conventional therap","cbCaimZWjVj4pxGM","https://ap.wps.com/l/cbCaimZWjVj4pxGM","pdf",16679678,12,"English","# Introduction\n## Wnt/β-catenin signaling and NSCLC\n## Role of FAM83A\n## Role of microRNAs in cancer\n# Results\n## Identification of miR-1 as a negative regulator of FAM83A","[{\"question\":\"Which miRNA was identified as a negative regulator of FAM83A in lung cancer?\",\"answer\":\"miR-1 was identified as a negative regulator of FAM83A in lung cancer.\"},{\"question\":\"How was the direct targeting relationship between miR-1 and FAM83A validated?\",\"answer\":\"The study confirmed FAM83A as a direct target gene of miR-1 using dual luciferase reporter assays.\"},{\"question\":\"What cellular effects did miR-1 overexpression have on NSCLC cells?\",\"answer\":\"Overexpression of miR-1 attenuated FAM83A expression and suppressed Wnt signaling, reduced β-catenin nuclear translocation, promoted β-catenin degradation, and inhibited NSCLC cell proliferation, migration, and invasion.\"}]","Screening and identification of miRNAs negatively regulating FAM83A/Wnt/β-catenin signaling pathway in non-small cell lung cancer - Research report | PDF",1790009430]